Germany – Counselling services – Prozessaufnahme der Arbeitsabläufe, insbesondere zur Geschäftsprozessoptimierung sowie Stellenbemessung.

General Public Services · Germany government procurement

Closed January 29, 2025. GlobalGov surfaces government procurement from around the world, including the markets your competitors overlook.

Closed
Status

Opportunity Overview

The aim of the study is to ensure the county can fulfill its tasks with the available resources, addressing the ongoing challenge of managing its responsibilities. In these times of skilled labor shortages, the introduction of process management aims to optimize business processes and staffing levels to ensure the timely and appropriate delivery of services by the departments under investigation. This will involve identifying and optimizing selected and relevant business processes to enable more resource-efficient and time-saving operations. The county is not aiming for either increased staffing or staff reductions. The focus will be on ensuring the continued accuracy of personnel needs assessments and identifying weaknesses in core processes to facilitate digitalization and business process optimization. Professional change management from the external partner is expected, preparing employees for potential changes and presenting the new target processes. Further details can be found in the tender documents.

Your competitors are watching the same crowded contracts everyone else is. Track live opportunities like this one worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.

Start Free

Solicitation Details

Issuing agencyGeneral Public Services
CountryGermany
CategoryPharmaceuticals
CPV85312320
PublishedJanuary 29, 2025
Procurement stageRequest for Proposal (RFP)
ClosedJanuary 29, 2025
StatusClosed — no longer accepting responses
TranslationTranslated from Hungarian by GlobalGov’s translation pipeline
Official sourceView original notice
Last verifiedAugust 12, 2026

Source: Tenders Electronic Daily (TED), © European Union. Notice content reused under Commission Decision 2011/833/EU; editorial content licensed CC BY 4.0. GlobalGov is not affiliated with the European Union.

Browse Similar Open Opportunities in Germany

Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Thalidomid, ATC L04AX02 (OBG) für die Zeit 01.11.2024 - 31.10.2026
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Formoterol/Glycopyrronium/Budesonid (ATC-Code nach WHO: R03AL11)
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Guanfacin, ATC N06BA21
Germany – Pharmaceutical products – Arzneimittel-Rabattverträge ab 01.09.2025 zu diversen Wirkstoffen im Rahmen eines Open-House-Verfahrens
Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 of the German Social Code, Book V (SGB V) for medicinal products containing the active ingredient iron carboxymaltose (ATC code: B03AC01).
Germany – Pharmaceutical products – Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Risperidon (ATC-Code N05AX08) eingeschränkt auf die Darreichung Pulver und Lösungsmittel zur Herstellung einer Depot-Injektionssuspension.
Germany – Pharmaceutical products – Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130 a Abs. 8 SGB V mit der Wirkstoffkombination Adapalen + Benzoylperoxid
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Peginterferon beta-1a, ATC L03AB13

See every Germany Pharmaceuticals opportunity your competition is missing. Free for 14 days.

Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.

Start Free Trial — No Card Required

Free 14-day trial · no card required

See who is already competing here →

Get a free Germany Pharmaceuticals intelligence report in your inbox

A personalized report on Germany Pharmaceuticals opportunities, emailed in 5-10 minutes. One per month, no account needed.